Careteq Ltd. · ASX:CTQ

Careteq — Investor Presentation (July 2023)

28 slides from Careteq's investor presentation, Jul 26, 2023

  1. Slide 1: Investor Presentation

    Investor Presentation July 2023 Constant care, everywhere

  2. Slide 2: Disclaimer and Important Notices

    Disclaimer and Important Notices The following notice and disclaimer applies to this investor presentation (Presentation) and you are therefore advised to as amended (the U.S. Securities Act) or the securities laws of any state or other jurisdiction of the United States. read this carefully before r

  3. Slide 3: Disclaimer and Important Notices

    Disclaimer and Important Notices Investment risk None of Careteq or its advisers or any of their respective affiliates, related bodies corporate, directors, officers, partners, employees and agents, have authorised, permitted or caused the issue, submission, dispatch or provision of this An investme

  4. Slide 4: Company Overview

    Company Overview Delivering innovative health and aged care solutions SaaS Based Devices Assisted Living Solutions Suite of devices for Intuitive, enterprise CARETEQ is an early Solutions targeting monitoring activity, level dashboard to acute, aged, disability safety and medication manage and contr

  5. Slide 5: Achievements Since Listing

    Achievements Step-Up in Revenue & Earnings 1HFY23 revenue up 36% Scaling Key Profit Centre Size of medication Additional Recurring Revenue Opportunity Exclusive licensing deal for Strong Since Listing and active subscribers up management business Care (electronic medication by ~50% to >4.2K jumped b

  6. Slide 6: Leveraged to Large Global Markets

    Leveraged to Large Global Markets Aged & disability care industry ripe for tech disruption CARETEQ closing in on cashflow breakeven inflection point ...driven by multiple tailwinds (15K subscriber target) Ageing Population Funding More room for growth... Rapidly aging population across the Governmen

  7. Slide 7: Business Model

    Software: Services: SaaS Platforms Embedded Health Solutions 3 SOLUTION Business Assistive Living Electronic Medication Medication Management Model Technology Management Services Commercially ready Cloud-based platform, SaaS-based system, Medication management services DESCRIPTION through its team o

  8. Slide 8: Assistive Living Technology

    Assistive Living Technology Investor Presentation | 8

  9. Slide 9: Sofihub Ecosystem

    SaaS Platform Scalable SaaS platform that provides critical data and AI-powered insights from best of breed hardware Real-time Data Constant real-time stream of multiple data variables delivering broad detail on activities and occurrences Easy Access Can be accessed through various devices including

  10. Slide 10: CARETEQ's Sales Cycle Explained

    Global SAM: $32B1 CARETEQ’s Sales Cycle Explained Channel partner go-to-market strategy Active Partners Won ONGOING CARETEQ leverages Active Partners’ client networks. Most Active Partners have large pool of existing clients across SALES Aged Care Facilities multiple verticals that they can sell CAR

  11. Slide 11: Sofihub Trials and Subscriptions

    Sofihub Trials Subscriptions FY24 goal: 15,000+ subs There are currently Converting just one of 18 trials running – the trials may lead to a 11 in the U.S. and 7 significant step change and cash flow breakeven in Australia in subscriber numbers run rate1 Growing subscriber base and ARPU No. 4.6K Bre

  12. Slide 12: U.S. Customer Example

    U.S. Customer Example CARETEQ has several similar sized opportunities in its US pipeline CARETEQ secured an Active Partner who is a leading The partner introduced CARETEQ to a large independent and An initial trial of TEQ-Secure was successfully completed If a contract is successfully executed, 40K

  13. Slide 13: Embedded Health Solutions

    Embedded Health Solutions Medication Management Services Investor Presentation | 13

  14. Slide 14: Medication Management

    Medication + Management Estimated EBITDA: $1.5m for FY241 Unlocking profit and growth Medication Management Services CARETEQ merged its Ward MM business with Mederev in a JV (via non-cash Revenue & Earnings Growth Platform transaction)1 called Embedded Health A key contributor to the Group’s Regulat

  15. Slide 15: New Revenue Opportunity with Global Pharmas

    New Revenue Opportunity with Global Pharmas Monetising high-value, high-margin data Too early to quantify Value of CARETEQ’s datasets the opportunity but the is increasing due to growth of high-value high-margin High Value of Data data lake1 offering could artificial intelligence (AI) In discussions

  16. Slide 16: Strong Care

    Strong Care Electronic Medication Management Investor Presentation | 16

  17. Slide 17: What is Strong Care?

    20hrs+ SAVED MONTHLY Nurses can expect to What is save 20+ hours in administrative tasks Strong Care? Innovative cloud-based 50% TIME REDUCTION medication management system Medication round for aged care times reduced up to 50% with the help of CARETEQ is the exclusive reseller of Strong automation

  18. Slide 18: Solid Growth Thematic

    The federal government is providing grants to RACs to make the digital transition by Dec 2024 ~60-70% of There are >200K RACs are still aged care using inefficient beds in Australia and paper-based digital subscriptions are charged by Solid systems per bed Those who don’t will Growth have to fund th

  19. Slide 19: Additional Opportunities and Outlook

    Additional Opportunities and Outlook Investor Presentation | 19

  20. Slide 20: Additional Growth Opportunities

    Lone Worker Market Initial sales of TEQ-Secure safety pendants via existing channel partner Early customers include Transport Domestic Accident Commission (TAC) and Hospital-in- Violence Department of Health the-Home Global lone worker safety market US non-profit combating Hospital-in-the-Home is gr

  21. Slide 21: Positive Outlook

    Positive Outlook Rapidly approaching earnings inflection point Approaching 1K contracted beds with Forecasting to reach an additional ~4K breakeven on Group under proposal since operating level with 15K launch in October subs in FY24 2022 Strong cross-selling opportunities for Sofihub & Strong Care

  22. Slide 22: Deep Experience in Health Care

    Deep Experience in Health Care Board Directors Mark Simari Alex Boyd Brett Cheong Stephen Munday Executive Chairman Executive Director / COO Non-Executive Director Non-Executive Director Over two decades of experience in Over 40 years of background Over 40 years business experience Over 15 years’ Bo

  23. Slide 23: Offer Overview

    Offer Overview Issuer Careteq Limited (ACN: 612 267 857) (“CARETEQ”, “CTQ” or the “Company”). Lead Manager Sequoia Corporate Finance Pty Ltd (“Sequoia” or the “Lead Manager”) Offer A capital raising of up to $2.47 million through the issuance of up to approximately 98.85 million new fully paid ordin

  24. Slide 24: $2.5M Capital Raising

    $2.5M Capital Raising Capital structure Pre-money Post-money Use Of Funds $M’s %’s Offer price $0.025 $0.025 Software Development 0.6 24% New shares – rights issue (m) 98.9 Sales & Marketing 0.7 28% Shares on issue (m) 123.6 222.4 General Working Capital 1.0 41% Market cap ($m) 3.1 5.61 Cost of Offe

  25. Slide 25: Indicative Offer Timetable

    Indicative Offer Timetable1 Indicative Offer Timetable1 Dates Trading Halt 25 July 2023 Bids due deadline (may close early) 9am, 26 July 2023 Allocations advised (if not already advised) & Return of executed firm acceptances 11am, 26 July 2023 Announce rights issue and recommence trading 27 July 202

  26. Slide 26: Risk Factors

    Risk Factors Topic Summary Summary of key risks Prospective investors should be aware that subscribing for Securities in the Company involves a number of risks. The risk factors set out below, and other general risks applicable to all investments in listed securities, may affect the value of the Sha

  27. Slide 27: Risk Factors

    Risk Factors Topic Summary Summary of key risks Foreign exchange risk The Company plans to operate across international borders and, as such the Company may be subject to adverse foreign exchange movements which may impact on the Company's financial performance and position. General economic climate

  28. Slide 28: Thank You

    Thank You MARK SIMARI Executive Chairman mark.simari@careteq.com.au SAMANTHA THOMPSON Investor Relations samantha.thompson@careteq.com.au Corporate Address CARETEQ Level 10 99 Queen Street Constant care, everywhere Melbourne, 3000

Careteq — Investor Presentation (July 2023) on 6ix